This approach identified PLA2G16 (HRASLS3), a class II tumor suppressor that exhibits promoter methylation and reduced expression levels in nasopharyngeal cancers [12, 17]. The gene discussed is PLAAT3; the disease is nasopharyngeal carcinoma.